- Investing Ideas
- /
- Norwegian Biotech Stocks
Norwegian Biotech Stocks
Results
12
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
12 companies
Photocure
Market Cap: NOK 1.3b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 50.40
7D
0.2%
1Y
-13.0%
Vistin Pharma
Market Cap: NOK 1.1b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 24.60
7D
-0.8%
1Y
9.8%
Hofseth BioCare
Market Cap: NOK 924.9m
Engages in the production of health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Europe, Japan, Asia, and the United States.
HBC
NOK 2.25
7D
-3.8%
1Y
7.1%
ArcticZymes Technologies
Market Cap: NOK 840.1m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 16.45
7D
0%
1Y
-36.7%
Thor Medical
Market Cap: NOK 770.3m
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 2.45
7D
-1.4%
1Y
131.6%
Norda
Market Cap: NOK 397.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 80.00
7D
-0.1%
1Y
95.1%
Navamedic
Market Cap: NOK 388.6m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.00
7D
3.8%
1Y
-36.6%
Zelluna
Market Cap: NOK 263.6m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 13.03
7D
-6.2%
1Y
n/a
SoftOx Solutions
Market Cap: NOK 186.0m
Operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.083
7D
-7.4%
1Y
-13.5%
EXACT Therapeutics
Market Cap: NOK 155.6m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 2.46
7D
-20.6%
1Y
-65.4%
Arctic Bioscience
Market Cap: NOK 92.7m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds.
ABS
NOK 3.45
7D
-6.8%
1Y
-66.2%
BerGenBio
Market Cap: NOK 74.9m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and immune-evasive in Norway.
BGBIO
NOK 1.92
7D
12.3%
1Y
-85.0%